Oleksandr Parkhomenko

6PUBLICATIONS
76CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Predictive and prognostic markersNephrology and urologyEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 31, 2026
Effects of Evolocumab on Mortality Outcomes in Patients Without Previous Myocardial Infarction or Stroke: A Prespecified Analysis of the VESALIUS-CV Randomized Clinical Trial.

|Aug 06, 2026
Analysis of Cytological Markers of Cellular Senescence in High-Risk Cardiovascular Patients After COVID-19.

|Sep 29, 2025
The Polypill (Acetyl Salicylic Acid, Atorvastatin, and Ramipril) Paradigm Shift in Secondary Prevention: Global Expert Delphi Consensus.

Daniel Piñeiro, José Ramón González-Juanatey, Ana Abreu

|May 25, 2024
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial.

Helen M Colhoun, Ildiko Lingvay, Paul M Brown

|Apr 06, 2024
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial.

Adrian F Hernandez, Jacob A Udell, W Schuyler Jones

Pageof 1

Frequent Collaborators

2 joint publications

Jose C Nicolau

2 joint publications

Marc S Sabatine

2 joint publications

Andrejs Erglis

2 joint publications

Lawrence A Leiter